ATE201698T1 - Immuntherapeutika gegen hiv - Google Patents

Immuntherapeutika gegen hiv

Info

Publication number
ATE201698T1
ATE201698T1 AT93920312T AT93920312T ATE201698T1 AT E201698 T1 ATE201698 T1 AT E201698T1 AT 93920312 T AT93920312 T AT 93920312T AT 93920312 T AT93920312 T AT 93920312T AT E201698 T1 ATE201698 T1 AT E201698T1
Authority
AT
Austria
Prior art keywords
hiv
antibody
protein
infected
mouse
Prior art date
Application number
AT93920312T
Other languages
English (en)
Inventor
Tsuneya Ohno
Original Assignee
Nissin Food Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1992/007111 external-priority patent/WO1993004090A1/en
Application filed by Nissin Food Products Ltd filed Critical Nissin Food Products Ltd
Priority claimed from PCT/US1993/007967 external-priority patent/WO1994004574A1/en
Application granted granted Critical
Publication of ATE201698T1 publication Critical patent/ATE201698T1/de

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93920312T 1992-08-24 1993-08-24 Immuntherapeutika gegen hiv ATE201698T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1992/007111 WO1993004090A1 (en) 1991-08-22 1992-08-24 Hiv immunotherapeutics
US3945793A 1993-04-22 1993-04-22
PCT/US1993/007967 WO1994004574A1 (en) 1991-08-22 1993-08-24 Hiv immunotherapeutics

Publications (1)

Publication Number Publication Date
ATE201698T1 true ATE201698T1 (de) 2001-06-15

Family

ID=26716145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93920312T ATE201698T1 (de) 1992-08-24 1993-08-24 Immuntherapeutika gegen hiv

Country Status (6)

Country Link
EP (1) EP0662093B1 (de)
JP (1) JP2888981B2 (de)
AT (1) ATE201698T1 (de)
AU (1) AU674539B2 (de)
CA (1) CA2122044C (de)
DE (1) DE69330280T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332911T2 (de) * 1993-08-24 2003-12-18 Nissin Food Products Ltd Rekombinanter humanisierter Antikörper gegen menschlichen Immunschwächevirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
WO1992001719A1 (en) * 1990-07-18 1992-02-06 Tanox Biosystems, Inc. Chimeric hiv-1-neutralizing immunoglobulins
CA2094611C (en) * 1991-08-22 2000-07-25 Tsuneya Ohno Hiv immunotherapeutics

Also Published As

Publication number Publication date
AU674539B2 (en) 1997-01-02
AU5089893A (en) 1994-03-15
EP0662093B1 (de) 2001-05-30
CA2122044A1 (en) 1994-03-03
DE69330280D1 (de) 2001-07-05
CA2122044C (en) 2003-07-29
DE69330280T2 (de) 2001-12-06
EP0662093A1 (de) 1995-07-12
JP2888981B2 (ja) 1999-05-10
EP0662093A4 (de) 1998-07-01
JPH07502539A (ja) 1995-03-16

Similar Documents

Publication Publication Date Title
CA2094611A1 (en) Hiv immunotherapeutics
US5922325A (en) Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection
US5911989A (en) HIV-vaccines
JP2020120689A5 (de)
Levi et al. A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.
AT398080B (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
ATE238420T1 (de) Rekombinanter humanisierter antikörper gegen menschlichen immunschwächevirus
US5854400A (en) Monoclonal antibodies which neutralize HIV-1 infection
RU93005284A (ru) Моноклональные антитела линии клеток, фармацевтические композиции, способы лечения, фрагмент антитела
US5834599A (en) Immunoconjugates which neutralize HIV-1 infection
JP2004518624A5 (de)
US20070292390A1 (en) Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies
US6241986B1 (en) Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV
US5445960A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
KR0149848B1 (ko) Hiv에 특이한 모노클로날 항체 및 그 제조용 하이브리도마
US6200575B1 (en) Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
ATE201698T1 (de) Immuntherapeutika gegen hiv
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
RU94024562A (ru) Антитело, полинуклеотид, клетка, способ получения антитела
CN1172717C (zh) 一种治疗艾滋病的药物及其制备方法
WO1993019786A1 (en) High affinity, strongly neutralizing monoclonal antibodies against the cd-4 binding site of gp120 of human immunodeficiency virus
JPS63500035A (ja) プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
CN1665842B (zh) 诱导HIV感染细胞凋亡的人IgM抗体和用于HIV感染的药物
CN1238499C (zh) 艾滋病病毒0型株的一种抗体及其生产细胞系与应用
RU2023130017A (ru) Антитело против человеческого tlr7

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties